Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
institute for clinical and economic review
3
×
life sciences
national blog main
national top stories
new york blog main
alnylam pharmaceuticals
boston
fda
harvard pilgrim health care
national
new york top stories
san diego blog main
san diego top stories
san francisco blog main
akcea therapeutics
alder biopharmaceuticals
amgen
amy schulman
andreas klein
anna greka
barry greene
biotech
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
car-t
caron jacobson
chronic migraine
cigall kadoch
clinical trials
craig mello
dan ollendorf
david rind
detroit blog main
detroit top stories
drugs
eli lilly
episodic migraine
What
drug
fda
gene
interference
medicines
rna
alnylam
amgen
approval
approves
aren’t
candidates
car
cells
class
cutting
developed
edge
ema
employ
europe
experiments
follows
gets
harmful
head
hits
hot
launch
make
market
medicine
method
migraine
mute
new
nod
pain
payers
photos
Language
Current search:
" institute for clinical and economic review "
×
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
